November 28, 2025

Neuropace, Inc. (NPCE) Investor Outlook: Analyst Consensus and 6% Potential Upside

Neuropace, Inc. (NASDAQ: NPCE), a pioneering player in the medical device industry, is drawing significant interest from the investment community. Specializing in innovative treatments for drug-resistant focal epilepsy, Neuropace’s RNS..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Potential Upside of Nearly 30% Amid Strong Analyst Ratings

OrthoPediatrics Corp. (NASDAQ: KIDS), a leader in the pediatric orthopedic medical device sector, presents an intriguing opportunity for investors looking to capitalize on its niche market positioning and growth potential...

Altimmune, Inc. (ALT) Stock Analysis: A 245% Potential Upside in the Biotechnology Sector

Altimmune, Inc. (NASDAQ: ALT), a biotechnology company operating out of Gaithersburg, Maryland, is capturing investor attention with its remarkable potential upside of 245.74%. Specializing in the development of treatments for..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Strong Buy Ratings and Promising Pipeline Fuel Investor Optimism

Cogent Biosciences, Inc. (NASDAQ: COGT), a biotechnology firm headquartered in Waltham, Massachusetts, is capturing the attention of investors with its robust development pipeline and promising future prospects. Specializing in precision..

CureVac N.V. (CVAC) Stock Analysis: Navigating the mRNA Innovator with a Potential Downside Amidst Industry Challenges

CureVac N.V. (NASDAQ: CVAC), a prominent player in the burgeoning field of mRNA technology, has captured investor attention with its innovative approach to developing transformative medicines. Headquartered in Tübingen, Germany,..

HealthStream, Inc. (HSTM) Stock Analysis: Exploring 34.28% Potential Upside with Robust SaaS Solutions

HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the Health Information Services industry, has been making waves in the healthcare sector with its innovative Software-as-a-Service (SaaS) solutions. Headquartered in Nashville,..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Unpacking the Biotech Player’s 52-Week Highs and Analyst Optimism

Sionna Therapeutics, Inc. (NASDAQ: SION) is capturing headlines and investor interest as a burgeoning player in the biotech sector, particularly due to its focus on innovative treatments for cystic fibrosis..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring a 27.76% Potential Upside in the Biotechnology Sector

Arbutus Biopharma Corporation (NASDAQ: ABUS) stands at a pivotal juncture in the biotechnology space, presenting an intriguing opportunity for investors keen on the healthcare sector. Despite its challenges, the company’s..

AxoGen, Inc. (AXGN) Stock Analysis: Navigating High Growth in the Medical Device Sector

AxoGen, Inc. (NASDAQ: AXGN), a company specializing in peripheral nerve regeneration technologies, is making waves in the healthcare sector with its innovative medical devices. Headquartered in Alachua, Florida, AxoGen is..

Immunome, Inc. (IMNM) Stock Analysis: Strong Buy Ratings and 32.73% Potential Upside

Immunome, Inc. (NASDAQ: IMNM), a clinical-stage biotechnology firm headquartered in Bothell, Washington, is capturing investor attention with its robust pipeline of targeted cancer therapies and a notable market capitalization of..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating the Healthcare Device Landscape with Strategic Focus

Avanos Medical, Inc. (AVNS), a key player in the healthcare sector, specializes in providing innovative medical device solutions across a global market. Headquartered in Alpharetta, Georgia, Avanos offers an array..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: 239% Potential Upside Makes It a Compelling Buy

Akebia Therapeutics, Inc. (NASDAQ: AKBA), a prominent player in the healthcare sector, is capturing investor attention with its potential upside of 239.62%. The company specializes in developing and commercializing therapeutics..

Oculis Holding AG (OCS) Stock Analysis: Exploring a Potential 127% Upside in Biotech Innovation

Oculis Holding AG (NASDAQ: OCS), a burgeoning name in the biotechnology sector, is poised to capture investor attention with its robust potential for growth in the high-stakes healthcare arena. Based..

AnaptysBio, Inc. (ANAB) Stock Analysis: A 51.59% Potential Upside Amidst Dynamic Biotech Innovations

AnaptysBio, Inc. (NASDAQ: ANAB), a San Diego-based biotechnology firm, is capturing investor attention with a market cap of $1.18 billion and a promising array of immunology therapeutics. Operating in the..

Community Health Systems, Inc. (CYH) Stock Analysis: Evaluating a 13.25% Potential Upside

Community Health Systems, Inc. (NYSE: CYH), a key player in the United States healthcare sector, operates a network of general acute care hospitals. With a market capitalization of $483.41 million,..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: A Biotech with 58% Potential Upside

Trevi Therapeutics, Inc. (NASDAQ: TRVI) is capturing the attention of investors with its promising pipeline in the biopharmaceutical sector. As a clinical-stage biotechnology company, Trevi focuses on developing therapies for..

Replimune Group, Inc. (REPL)

⚠️ No article content returned.

..

Praxis Precision Medicines, Inc (PRAX): Investor Outlook Reveals 71.81% Potential Upside in CNS Therapy Innovations

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a forefront player in the biotechnology sector, is capturing investor attention with its ambitious portfolio of therapies targeting central nervous system (CNS) disorders. With..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: A Biotech Gem With 74% Upside Potential

Investors seeking opportunities in the biotechnology sector should turn their attention to LENZ Therapeutics, Inc. (NASDAQ: LENZ). With a market capitalization nearing $1 billion and a potential upside of 74.15%,..

Owens & Minor, Inc. (OMI) Stock Analysis: Exploring a Potential 107% Upside for Investors

Owens & Minor, Inc. (NYSE: OMI), a prominent player in the healthcare sector, is navigating a challenging market environment. Operating through its two primary segments, Products & Healthcare Services and..

Search

Funds

November 28, 2025

Search

Funds

November 28, 2025

FTSE 100

Funds